SCHEMBL3533567

SCHEMBL3533567

Cn1c(C2CC2)cc(=O)n1-c1cccc(F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.41
MGLL Q99685 1/20 0.41
ALOX5 P09917 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NAPRT Q6XQN6 1/20 0.40
POLB P06746 2/20 0.38
HTR7 P34969 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
GRM2 Q14416 1/20 0.38
FADS1 O60427 1/20 0.36
ACHE P22303 1/20 0.36
BPTF Q12830 1/20 0.36
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35
DRD2 P14416 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3529011 0.84 NAPRT (0.41) MGLLALOX5MEN1KMT2AL3MBTL1
SCHEMBL3530770 0.84 NAPRT (0.39) MGLLMEN1KMT2ANAPRTPOLB
SCHEMBL3531384 0.83 NAPRT (0.57) MEN1KMT2ANAPRTPOLBHTR7
SCHEMBL3533117 0.82 CYP17A1 (0.45) ALOX5MEN1KMT2AHTR7ALDH1A1
SCHEMBL3533392 0.82 GRM2 (0.38) FAAHMGLLALOX5MEN1KMT2A
SCHEMBL3528700 0.78 GRIA1 (0.35) L3MBTL1HTR7GRM2DRD2
SCHEMBL3533603 0.78 NAPRT (0.54) KMT2ANAPRTHTR7ALDH1A1
SCHEMBL3535358 0.77 HSD11B1 (0.38) L3MBTL1ALDH1A1GRM2
SCHEMBL3535467 0.77 MEN1 (0.41) MGLLMEN1KMT2ANAPRTALDH1A1
SCHEMBL3532450 0.75 HSD11B1 (0.42) FAAHMGLLALOX5MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7652057-B2 Pyrazolones as 11b-HSD1 inhibitors for diabetes HOFFMAN-LA ROCHE INC. (US) 2010-01-26 US disclosed
EP-1924562-A2 PYRAZOLONE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-05-28 EP disclosed
WO-2007025880-A2 PYRAZOLONE DERIVATIVES AS 11-BETA HSD1 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2007-03-08 WO disclosed
US-20070049574-A1 New pyrazolones as 11b-HSD1 inhibitors for diabetes F. HOFFMANN-LA ROCHE AG (CH) 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049574-A1 New pyrazolones as 11b-HSD1 inhibitors for diabetes HSD11B1, HSD17B1, HSD17B7 FAAH 2720/4885MGLL 2403/4885ALOX5 1604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.